Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 329740

Development of phage derived scFv : porphyrin conjugates for use in photodynamic therapy of cancer


Staneloudi, Chrysovalanto; Smith, Karen A.; Hudson, Robert; Pesa, Nela; Savoie, Huguette; Boyle, Ross W.; Greenman, John
Development of phage derived scFv : porphyrin conjugates for use in photodynamic therapy of cancer // Immunology / Altman, Danny (ur.).
Oxford: Blackwell Publishing, 2005. str. 35-35 (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 329740 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Development of phage derived scFv : porphyrin conjugates for use in photodynamic therapy of cancer

Autori
Staneloudi, Chrysovalanto ; Smith, Karen A. ; Hudson, Robert ; Pesa, Nela ; Savoie, Huguette ; Boyle, Ross W. ; Greenman, John

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Immunology / Altman, Danny - Oxford : Blackwell Publishing, 2005, 35-35

Skup
Annual BSI Congress

Mjesto i datum
London, Velika Britanija, 06-09.12.2005

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Photodynamic therapy; scFv; Phage display; Porphyrin; Bioconjugation

Sažetak
Photodynamic therapy has become a useful tool in oncology but is limited by side effects caused by a lack of targeting of the photosensitiser. This problem can be circumvented by the conjugation of photosensitisers, such as porphyrins, to tumour specific monoclonal antibodies or alternatively to single chain (sc) Fv fragments which retain the same binding specificity but are more efficient at penetrating tumour masses due to their smaller size. A panel of scFv antibodies were previously isolated from the Nissim library after panning against colorectal cell lines. LAG3 was selected for expression and purification on the basis of good binding by flow cytometry and efficient expression of soluble scFv fragments. The LAG3 scFv was conjugated to 5 isothiocyanateporphyrins at different molar ratios. Flow cytometric analysis showed that most of the scFv conjugates maintained the binding ability of the parent scFv across a range of loading ratios. In vitro cytotoxicity assays against colorectal celllines gave promising results for the killing ability of these immunoconjugates, suggesting that scFv:porphyrin conjugates show promise for use as an antibody-targeted photodynamic strategy.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Biologija, Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
Sveučilište u Osijeku - Odjel za kemiju

Profili:

Avatar Url Nela Malatesti (autor)


Citiraj ovu publikaciju:

Staneloudi, Chrysovalanto; Smith, Karen A.; Hudson, Robert; Pesa, Nela; Savoie, Huguette; Boyle, Ross W.; Greenman, John
Development of phage derived scFv : porphyrin conjugates for use in photodynamic therapy of cancer // Immunology / Altman, Danny (ur.).
Oxford: Blackwell Publishing, 2005. str. 35-35 (poster, međunarodna recenzija, sažetak, znanstveni)
Staneloudi, C., Smith, K., Hudson, R., Pesa, N., Savoie, H., Boyle, R. & Greenman, J. (2005) Development of phage derived scFv : porphyrin conjugates for use in photodynamic therapy of cancer. U: Altman, D. (ur.)Immunology.
@article{article, editor = {Altman, D.}, year = {2005}, pages = {35-35}, keywords = {Photodynamic therapy, scFv, Phage display, Porphyrin, Bioconjugation}, title = {Development of phage derived scFv : porphyrin conjugates for use in photodynamic therapy of cancer}, keyword = {Photodynamic therapy, scFv, Phage display, Porphyrin, Bioconjugation}, publisher = {Blackwell Publishing}, publisherplace = {London, Velika Britanija} }
@article{article, editor = {Altman, D.}, year = {2005}, pages = {35-35}, keywords = {Photodynamic therapy, scFv, Phage display, Porphyrin, Bioconjugation}, title = {Development of phage derived scFv : porphyrin conjugates for use in photodynamic therapy of cancer}, keyword = {Photodynamic therapy, scFv, Phage display, Porphyrin, Bioconjugation}, publisher = {Blackwell Publishing}, publisherplace = {London, Velika Britanija} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font